UnitVisID rebrands to lead RFID use in healthcare

DoseID Consortium, the first membership-driven industry alliance advancing radio-frequency identification (RFID) technology in pharmaceuticals, has rebranded to UnitVisID Alliance to reflect the organization’s efforts around medication visibility and the benefits to hospitals and the supply chain.

DoseID Consortium has rebranded to UnitVisID Alliance to reflect the organization’s efforts around medication visibility and the benefits to hospitals and the supply chain

The name change reflects the organization’s commitment and mission to ensure the quality, performance, and interoperability of RFID-tagged pharmaceutical products as they move through the supply chain – from manufacturing to patient use.  

The confluence of the Covid-19 pandemic, drug shortages, and staff shortages have accelerated RFID technology adoption. Emergen Research forecasts that the market for RFID in healthcare will reach almost 15 billion USD in 2028 globally from 4.24 billion USD in 2020.  

With advancements in technology and innovation, RFID-tagged pharmaceutical products in the healthcare industry present opportunities to improve inventory management and, ultimately, better patient outcomes. Currently, UnitVisID is used by more than 1,000 hospitals and healthcare organizations, and more than 210 million RFID-tagged products utilizing the UnitVisID platform have been scanned, more than any other RFID system in the US healthcare space. 

‘We've realized the many benefits of RFID in healthcare, and its massive adoption is a testament that we are now at a tipping point,’ said Tim Kress-Spatz, president at UnitVisID Alliance. ‘The rebrand reflects this change, and to tackle the challenges of shortages, recalls, workflow inefficiencies, and lack of interoperability, it requires a whole of industry approach from the entire healthcare supply chain.’

The Alliance provides a unified approach with research, tools, and resources for the healthcare industry that ensures RFID-tagged pharmaceutical products work in all downstream systems in hospitals and healthcare systems. UnitVisID is open to hospitals and industry organizations. Current industry members span the pharmaceutical manufacturing ecosystem and include RFID companies, pharmaceutical manufacturers, 503B outsourcing facilities, technology, and automation vendors, label converters, and service suppliers.  

The UnitVisID Alliance membership represents many of today’s leading companies in the pharmaceutical manufacturing ecosystem, including Avery Dennison Corporation, Baxter, CCL Healthcare, George Schmitt & Co., Hikma, Identiv, Impinj, Intelligent Label Solutions, International Medical Industries, Inc., Kit Check, MPI Label Systems, Nephron, Omnicell, Sandoz, SCHOTT Pharmaceutical Systems, Schreiner MediPharm, and Tageos.

Related content